Similarly, fibroblast growth factor receptor 2 (FGFR2) is also implicated in cell proliferation, differentiation and motility, and amplification of the FGFR2 gene plays an important role in the tumorigenesis of GC, thereby underscoring its attraction as drug development target [14–16]. The gene discussed is FGFR2; the disease is gastric cancer.